美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
STAVUDINE; LAMIVUDINE	021838	001	NDA	STAVUDINE; LAMIVUDINE	TABLET; ORAL	40MG; 150MG	No	No	2007/03/13 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE W/NEVIRAPINE	021854	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2007/03/13 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; EFAVIRENZ	022097	001	NDA	STAVUDINE; LAMIVUDINE; EFAVIRENZ	TABLET; ORAL	40MG; 150MG; 600MG	No	No	2007/06/01 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	021837	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2008/03/20 (TA)	--	STRIDES ARCOLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022177	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2008/03/20 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022346	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2009/02/27 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022346	002	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2009/02/27 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE	022347	001	NDA	STAVUDINE; LAMIVUDINE	TABLET; ORAL	30MG; 150MG	No	No	2009/03/18 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE	022347	002	NDA	STAVUDINE; LAMIVUDINE	TABLET; ORAL	40MG; 150MG	No	No	2009/03/18 (TA)	--	PHARMACARE LTD	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022342	001	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	30MG; 150MG; 200MG	No	No	2009/07/16 (TA)	--	EMCURE PHARMA	None (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINE	022342	002	NDA	STAVUDINE; LAMIVUDINE; NEVIRAPINE	TABLET; ORAL	40MG; 150MG; 200MG	No	No	2009/07/16 (TA)	--	EMCURE PHARMA	None (Tentative Approval)